2-甲氧基羰基-4-甲氧基苯硼酸 | 1256355-40-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-甲氧基羰基-4-甲氧基苯硼酸
• 英文名称: (4-methoxy-2-(methoxycarbonyl)phenyl)boronic acid
• 英文别名: (4-methoxy-2-methoxycarbonylphenyl)boronic acid
• CAS: 1256355-40-4
• 化学式: C₉H₁₁BO₅
• 分子量: 209.994
• InChiKey: QJEMXKRTNMWVHO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.84
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  76
• 氢给体数：
  2
• 氢受体数：
  5

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Methoxycarbonyl-4-methoxyphenylboronic acid
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Methoxycarbonyl-4-methoxyphenylboronic acid
CAS number: 1256355-40-4

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, under −20◦C.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H11BO5
Molecular weight: 210.0

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-甲氧基羰基-4-甲氧基苯硼酸 在 四(三苯基膦)钯 、 sodium carbonate 、 potassium carbonate 作用下， 以 乙二醇二甲醚 、 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 36.0h， 生成 8-methoxy-3-((tetrahydro-2H-pyran-4-yl)methoxy)-6H-benzo[c]chromen-6-one
  参考文献：
  名称：

  一种尿石素类化合物、制备方法、药物组合物及用途

  摘要：

  本发明属于药物化学领域，具体涉及一种尿石素类化合物、制备方法、药物组合物及用途。该尿石素类化合物为通式I所示的化合物或其旋光异构体、对映体、非对映体、外消旋体或外消旋混合物，或其药学上可接受的盐。本发明所提供的尿石素类化合物，具有较好的PDE2抑制活性，酶学水平IC50达到3.67μM，能够用于治疗中枢神经系统疾病和大脑的神经变性过程疾病，作为活性成分制备抑制PDE2活性的药物。

  公开号：

  CN113336735B
• 作为产物：
  描述：

  2-溴-5-甲氧基苯甲酸甲酯 在 (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride 、 potassium acetate 作用下， 以 1,4-二氧六环 、 水 、 丙酮 为溶剂， 反应 72.0h， 生成 2-甲氧基羰基-4-甲氧基苯硼酸
  参考文献：
  名称：

  在环境条件下使用硼酸/全氟频哪醇系统进行真正有机催化贝克曼重排的范围和机制

  摘要：

  羟基官能团的催化活化对于药物和商品化学品的生产具有重要意义。在这里，2-烷氧基羰基-和 2-苯氧基羰基-苯基硼酸被确定为在贝克曼重排中直接和化学选择性活化肟 N-OH 键的有效催化剂。这种经典的有机反应提供了一种独特的方法来制备官能化的酰胺产物，使用传统的羧酸和胺之间的酰胺偶联可能难以获得这些产物。在极性溶剂混合物中仅使用 5 mol% 的硼酸催化剂和全氟频哪醇作为添加剂，操作简单的方案具有条件温和、底物范围广和官能团耐受性高的特点。种类繁多的二芳基、芳基-烷基、杂芳基-烷基、和二烷基肟在环境条件下反应以提供高产率的酰胺产物。游离醇、酰胺、羧酸酯和许多其他官能团与反应条件相容。对催化循环的研究揭示了一种新型的硼诱导的肟酯交换，它提供了一种酰基肟中间体，参与了完全催化的非自蔓延贝克曼重排机制。酰基肟中间体独立制备并经受反应条件。它被发现是自给自足的；它反应迅速，单分子，不需要游离肟。一系列对照实验和

  DOI：

  10.1021/jacs.8b01618

文献信息

• Carboxy-directed asymmetric hydrogenation of α-alkyl-α-aryl terminal olefins: highly enantioselective and chemoselective access to a chiral benzylmethyl center
  作者：Shuang Yang、Shou-Fei Zhu、Na Guo、Song Song、Qi-Lin Zhou

  DOI：10.1039/c4ob00018h

  日期：——

  A carboxy-directed asymmetric hydrogenation of α-alkyl-α-aryl terminal olefins was developed by using a chiral spiro iridium catalyst, providing a highly efficient approach to the compounds with a chiral benzylmethyl center. The carboxy-directed hydrogenation prohibited the isomerization of the terminal olefins, and realized the chemoselective hydrogenation of various dienes. The concise enantioselective

  通过使用手性螺铱催化剂开发了α-烷基-α-芳基末端烯烃的羧基定向不对称氢化反应，为具有手性苄甲基中心的化合物提供了一种高效的方法。羧基定向的氢化阻止了末端烯烃的异构化，并实现了各种二烯的化学选择性氢化。通过使用该催化不对称氢化作为关键步骤，可以实现（S）-姜黄二醇和（S）-姜黄烯的简明对映选择性合成。
• [EN] UROLITHIN DERIVATIVES AND METHODS OF USE THEREOF<br/>[FR] DÉRIVÉS D'UROLITHINE ET LEURS PROCÉDÉS D'UTILISATION
  申请人：VANDRIA SA

  公开号：WO2022162471A1

  公开（公告）日：2022-08-04

  Disclosed are compounds, compositions, and methods useful for treating neuronal and mitochondrial diseases.

  本发明涉及用于治疗神经元和线粒体疾病的化合物、组合物和方法。
• THERAPEUTIC USES OF UROLITHIN DERIVATIVES
  申请人：[en]VANDRIA SA

  公开号：WO2024025953A2

  公开（公告）日：2024-02-01

  Disclosed are methods for treating a neuromuscular disorder, muscle disorder, heart disease, pulmonary fibrosis, liver disease, inflammatory bowel disease, or cancer. Also disclosed is a method of enhancing cancer immunotherapy.